Deliverables & Milestones

D8.7 Report on dissemination (including publications) and networking activities

D9.2 Development of the logo and website.

D9.3 Report on communication activities and impact on social media.

MS1 - Obtaining all ethical approvals

MS2 - Potential alerts regarding the implementation of the clinical study

MS3 - New Scientific discoveries on the shared pathophysiology between the retina and the brain in the setting of T2D and its therapeutic implications

MS4 - Identification of technologies based on retinal evaluation and circulating biomarkers for early detection of cognitive impairment in T2D

MS5 - Definition of clinical phenotypes of T2D more prone to dementia and generation of a protocol for risk stratification of cognitive decline.

MS6 - Results of audits sent by EC